Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial. (2020)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/md.0000000000020458
PubMed Identifier: 32590730
Publication URI: http://europepmc.org/abstract/MED/32590730
Type: Journal Article/Review
Volume: 99
Parent Publication: Medicine
Issue: 26
ISSN: 0025-7974